VerifiedRx

2021-12

Episodes

Tuesday Dec 14, 2021

Dr. Jason Goodchild, Vice President of Clinical Affairs at Premier Dental Products Company, and Dr. Mark Donaldson, Associate Principal in Pharmacy Advisory Solutions at Vizient discuss the merits of a recent statement on antibiotic prophylaxis for infective endocarditis with host Gretchen Brummel.
 
Guest speakers:
Jason Goodchild, DMD
Vice President of Clinical Affairs
Premier Dental Products Company
 
Mark Donaldson, BSP, ACPR, PHARMD, FASHP, FACHE
Associate Principal, Pharmacy Advisory Solutions
Vizient
 
Moderator:
Gretchen Brummel, PharmD, BCPS
Pharmacy Executive Director
Vizient Center for Pharmacy Practice Excellence
 
Show Notes:
[00:53-1:55] Antibiotic prophylaxis against infective endocarditis as an important tool
[01:56-2:48] Risks of over- or underutilization of this treatment modality
[02:49-4:52] History of the guidelines
[04:53-5:48] New statement impacts moving forward
[05:49-8:49] Doxycycline as alternative to clindamycin in penicillin-allergic patients
[08:50-9:47] The rationale to abandon clindamycin
[09:48-11:49] How clindamycin compares to other agents
[11:50-12:59] The bottom line
 
Links | Resources:
Prevention of Viridans group Streptococcal infective endocarditis: a scientific statement from the American Heart Association: Click here
Prevention of infective endocarditis: guidelines from the American Heart Association: Click here
Antibiotic prophylaxis guidelines: is there new information for 2021? Click here
 
Subscribe Today!
Apple Podcasts
Amazon Podcasts
Google Podcasts
Spotify
Stitcher
Android
RSS Feed

Tuesday Dec 07, 2021

Megan LaBreck, Antiarrhythmic Clinic Pharmacist at OhioHealth and winner of the Vizient Pharmacy Vision Award for Excellence in Innovation, discusses her program that transfers the management of nearly 1,400 patients on an antiarrhythmic drug and their monitoring from the exclusive management of a physician to a pharmacist-led service with host Gretchen Brummel.
 
Guest speakers:
Megan LaBreck, PharmD, BCPS, CACP
Antiarrhythmic Pharmacist
OhioHealth
 
Moderator:
Gretchen Brummel, PharmD, BCPS
Pharmacy Executive Director
Vizient Center for Pharmacy Practice Excellence
 
Show Notes:
[01:00-2:30] Transferring the management of nearly 1,400 patients on antiarrhythmic drugs and monitoring from a physician to a pharmacist-led service
[02:32-4:05] Solving the problem from the pharmacy point of view
[04:06-5:00] Identifying complexities and fixing issues
[05:01-6:06] Where did the idea come from for this program
[06:07-6:49] Designing the collaborative practice agreement    
[06:50-7:41] Training necessary to offer these services
[07:42-10:09] Discovering other opportunities
[10:10-11:53] Impact of shifting this activity to an outpatient setting
[11:55-13:01] How the program influenced patient satisfaction
[13:02-14:03] Future plans
[14:04-15:38] Advice for new practitioners or frontline staff
 
Links | Resources:
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Click here
Comparison of QT Interval Readings in Normal Sinus Rhythm Between a Smartphone Heart Monitor and a 12-Lead ECG for Healthy Volunteers and Inpatients Receiving Sotalol or Dofetilide: Click here
2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: Click here
Vizient Pharmacy Vision Awards: Excellence in Innovation: Click here
Vizient Pharmacy Vision Awards: Click here
 
Subscribe Today!
Apple Podcasts
Amazon Podcasts
Google Podcasts
Spotify
Stitcher
Android
RSS Feed

Copyright 2024 All rights reserved.

Version: 20230822